Tenofovir Disoproxil Fumarate Is Superior to Entecavir in Reducing Hepatitis B Surface Antigen for Chronic Hepatitis B in China: 2-Year Comprehensive Comparative Result of a Matched Comparative Study

Aim: Tenofovir disoproxil fumarate (TDF) and entecavir (ETV) are equally recommended as the first-line antiviral treatments for chronic hepatitis B (CHB) at present. We aimed to compare the long-term efficacy and safety between ETV and TDF therapy in CHB patients who had not received nucleoside anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Sisi, Ma, Xueqing, Cai, Chengwei, Wang, Huanqiu, Xiao, Fenqiang, Yu, Chengbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005520/
https://www.ncbi.nlm.nih.gov/pubmed/33791326
http://dx.doi.org/10.3389/fmed.2021.637126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005520/
https://www.ncbi.nlm.nih.gov/pubmed/33791326
http://dx.doi.org/10.3389/fmed.2021.637126

Ejemplares similares